StockTipsArenaBeta

BUY Sun Pharma Advanced Research Company Limited — Rajesh Palviya, Axis Securities

BUYSun Pharma Advanced Research Company Limited
Sun Pharma Advanced Research Company share price target & all analyst calls

byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))22 May 2026via ET Now

Entry₹202Stated
Target₹240
Total upside +18.81% (call closed)
Stop lossNot given
At expiry₹203.258 Jun 2026, 3:30 pm
Expired+0.62%
Follow Rajesh Palviya for new calls(27% target hit, 179 closed calls)Get alertsWatch SPARC for new buy/sell callsGet alertsSee 161 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 23 Oct, 7:20 pm IST
0 supporting1 neutral0 opposing
Supports the BUY call (0)

Nothing found in this tip’s window yet.

Neutral / worth noting (1)

Sun Pharma Advanced Research Company Limited has submitted to the Exchange, the financial results for the quarter and financial year ended March 31, 2026.

NSE · Outcome of Board Meeting·18 May · 3w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharma Advanced Research Company

All analyst calls on Sun Pharma Advanced Research Company

More from Rajesh Palviya, Axis Securities

Every call and its outcome